Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5 years of follow-up

Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5 years of follow-up

Abstract Background The aim of this study was to evaluate long-term efficacy and survival prognostic factors of stereotactic body radiation therapy (SBRT) for un-resectable liver metastases in patients enrolled in a prospective phase II trial. Methods and materials 5-year local control (LC), overall...

Full description

Bibliographic Details
Main Authors: Marta Scorsetti, Tiziana Comito, Elena Clerici, Ciro Franzese, Angelo Tozzi, Cristina Iftode, Lucia Di Brina, Pierina Navarria, Pietro Mancosu, Giacomo Reggiori, Antonella Fogliata, Stefano Tomatis, Guido Torzilli, Luca Cozzi
Format: Article
Language:English
Published: BMC 2018-11-01
Series:Radiation Oncology
Subjects:
Metastatic liver cancer
SBRT
SABR
Volumetric modulated arc therapy
Online Access:http://link.springer.com/article/10.1186/s13014-018-1185-9

Internet

http://link.springer.com/article/10.1186/s13014-018-1185-9

Similar Items